Although Foxf2 is differentially expressed between the stromal cells at the mouse proximal and distal prostatic ducts, it is technically infeasible to evaluate the impact of this differential expression pattern on tumor initiation and progression. This evidence concerns the gene FOXF2 and neoplasm.